Published in Women's Health Weekly, October 10th, 2002
The test, to be marketed under the name of IDI-Strep B and run on Cepheid's Smart Cycler instrument, is intended to be used as an aid in detecting the presence of GBS in pregnant women at the time they enter labor and delivery.
According to an article appearing in The New England Journal of Medicine, "Group B streptococcus is a leading cause of sepsis, meningitis, and death among newborn infants in Western countries. Early-onset infections (those...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Women's Health Weekly